Matthew A. Cooper

36.2k citations

364 papers · 23.5k indexed · 12 hit papers · h-index 68

Impact in

Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
Microbiology top 0.1%
- Antimicrobial Peptides and Activities

Papers in

Molecular Medicine 41
- Antibiotic Resistance in Bacteria 41
Microbiology 36
- Antimicrobial Peptides and Activities 35

Co-authors: Mark S. Butler Mark A. T. Blaskovich Avril A. B. Robertson Philip M. Hansbro Alysha G. Elliott Philip Hugenholtz Dudley H. Williams David Wood
Journals: ACS Infectious Diseases (12 papers)Journal of Medicinal Chemistry (8 papers)Australian Journal of Chemistry (6 papers)Scientific Reports (6 papers)Antimicrobial Agents and Chemotherapy (6 papers)
Partner nations: Australia United Kingdom United States

In The Last Decade

Matthew A. Cooper

360 papers receiving 23.1k citations

Hit Papers

12 papers align trajectories log scale

Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome 2018 · 472 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Journal of the American College of Cardiology
2018 Science Translational Medicine
2017 American Journal of Respiratory and Critical Care Medicine
2017 Journal of Hepatology
2017 Science
2016 Nature Reviews Microbiology
2016 Microbiome
2016 Immunity
2016 Brain Behavior and Immunity
2014 Natural Product Reports
2011 Nature
2002 Nature Reviews Drug Discovery

Peers

Countries citing papers authored by Matthew A. Cooper

Since Specialization

Citations

This map shows the geographic impact of Matthew A. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Cooper more than expected).

Fields of papers citing papers by Matthew A. Cooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Cooper. The network helps show where Matthew A. Cooper may publish in the future.

Co-authors

The 25 scholars most cited alongside Matthew A. Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew A. Cooper Line = papers co-authored together Matthew A. Cooper links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson’s disease models Brain ·Eduardo A. Albornoz, Karine Mardon, Rajiv Bhalla, Vinod Kumar, Charlène Prieto, Gary Cowin, Wenqing Mi, Mark S. Butler, Ruby Pelingon, Richard D. Gordon, Rebecca C. Coll, Kate Schroder, Reena Halai, Angus M. MacLeod, Kim L. Matthews, Avril A. B. Robertson, Matthew A. Cooper, Trent M. Woodruff	2025	0
2	Amino Alcohols as Potential Antibiotic and Antifungal Leads Molecules ·Jennifer R. Baker, Peter J. Cossar, Mark A. T. Blaskovich, Alysha G. Elliott, Johannes Zuegg, Matthew A. Cooper, Peter J. Lewis, Adam McCluskey	2022	3
3	Systematic Down-Selection of Repurposed Drug Candidates for COVID-19 International Journal of Molecular Sciences ·Christopher A. MacRaild, S Kottász, Faheem Faheem, Sankaranarayanan Murugesan, Velasquez Reynaga, Joanna Bryndza, Carl M. J. Kirkpatrick, Matthew A. Cooper, Enzo A. Palombo, Moana Simpson, André Landin Malt, Pei Xin Chen, Alexander J. McAuley, Anupama Kumar, Darren J. Creek, Natalie L. Trevaskis, Seshadri S. Vasan	2022	3
4	Syzygium cumini(L.),Skeels fruit extracts: In vitro and in vivo anti-inflammatory properties Journal of Ethnopharmacology ·Muhammad Qamar, Saeed Akhtar, Tariq Ismail, Ye Yuan, Naveed Ahmad, Abdul Tawab, Amir Ismail, Ross Barnard, Matthew A. Cooper, Mark A. T. Blaskovich, Zyta M. Ziora	2021	55
5	Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes Journal of Visualized Experiments ·M. Rhia L. Stone, Wanida Phetsang, Matthew A. Cooper, Mark A. T. Blaskovich	2020	1
6	TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental Insulin Resistance in Aging and Obesity Cell Reports ·José J. Fuster, María A. Zuriaga, Virginia Zorita, Susan MacLauchlan, Maya N. Polackal, Vanesa Viana‐Huete, Stephan Schwarze, Nuria Matesanz, Andrea Herrero-Cervera, Zhanxin Yang, Matthew A. Cooper, Herminia González‐Navarro, Kenneth Walsh	2020	132
7	An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria Nature Communications ·Alysha G. Elliott, Johnny X. Huang, Søren Neve, Johannes Zuegg, Ingrid A. Edwards, Amy K. Cain, Christine J. Boinett, Lars Barquist, Carina Vingsbo Lundberg, Jason A. Steen, Mark S. Butler, Mehdi Mobli, 景柱木村, Mark A. T. Blaskovich, Sergio Lociuro, Magnus Strandh, Matthew A. Cooper	2020	142
8	Detection and quantification of Staphylococcus aureus heterogeneity to identify antibiotic-induced persistence Access Microbiology ·朱雪黎, Mark S. Butler, Andrea Ranzoni, Matthew A. Cooper	2019	1
9	Antimicrobial anilinium polymers: The properties of poly(N,N‐dimethylaminophenylene methacrylamide) in solution and as coatings Journal of Polymer Science Part A Polymer Chemistry ·Ao Chen, J Mirembe, Cheng Zhang, McInnes Scott, WU Zhengkun, Hang T. Ta, Alysha G. Elliott, Matthew A. Cooper, Janesha Perera, Simon Swift, Idriss Blakey, Andrew K. Whittaker, Hui Peng	2019	7
10	Structure-Function Studies of Polymyxin B Lipononapeptides Molecules ·Alejandra Gallardo‐Godoy, Karl A. Hansford, Craig Muldoon, Bernd Becker, Alysha G. Elliott, Johnny X. Huang, Ruby Pelingon, Mark S. Butler, Mark A. T. Blaskovich, Matthew A. Cooper	2019	31
11	Elucidating the effect of sequence and degree of polymerization on antimicrobial properties for block copolymers Polymer Chemistry ·Stephanie M. Barbon, Nghia P. Truong, Alysha G. Elliott, Matthew A. Cooper, Thomas P. Davis, Michael R. Whittaker, Craig J. Hawker, Athina Anastasaki	2019	34
12	The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins Glia ·柘植千明, John D. Lee, Eduardo A. Albornoz, Luke McAlary, Cyril J. Jagaraj, Avril A. B. Robertson, Julie D. Atkin, Matthew A. Cooper, Kate Schroder, Justin J. Yerbury, Richard D. Gordon, Trent M. Woodruff	2019	154
13	Multifactorial chromosomal variants regulate polymyxin resistance in extensively drug-resistant Klebsiella pneumoniae Microbial Genomics ·Miranda E. Pitt, Alysha G. Elliott, Minh Duc Cao, Devika Ganesamoorthy, Ilias Karaiskos, Helen Giamarellou, Cely Saad Abboud, Mark A. T. Blaskovich, Matthew A. Cooper, Lachlan Coin	2018	54
14	Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate Journal of Antimicrobial Chemotherapy ·Miranda E. Pitt, Minh Duc Cao, Mark S. Butler, Soumya Ramu, Devika Ganesamoorthy, Mark A. T. Blaskovich, Lachlan Coin, Matthew A. Cooper	2018	14
15	Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome The Journal of Experimental Medicine ·Viola Neudecker, Moritz Haneklaus, Owen Jensen, Ludmila Khailová, Joanne C. Masterson, Hazel Tye, Kathryn A. Biette, Paul Jedlicka, Kelley S. Brodsky, Mark E. Gerich, Matthias Mack, Avril A. B. Robertson, Matthew A. Cooper, Glenn T. Furuta, Charles A. Dinarello, Luke O'neill, Holger K. Eltzschig, Seth L. Masters, Eóin N. McNamee	2017	305
16	Lipocalin-2 induces NLRP3 inflammasome activation via HMGB1 induced TLR4 signaling in heart tissue of mice under pressure overload challenge. Queensland's institutional digital repository (The University of Queensland) ·Erfei Song, James W.S. Jahng, Jun-Xian Shen, Hye Kyoung Sung, Meng Han, Rachel H. Toczydlowski, Donghai Wu, Stellar Boo, Boris Hinz, Matthew A. Cooper, Avril A. B. Robertson, Thorsten Berger, Tak W. Mak, Isaac George, P. Christian Schulze, Yu Wang, Aimin Xu, Gary Sweeney	2017	45
17	Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice Science ·José J. Fuster, Susan MacLauchlan, María A. Zuriaga, Maya N. Polackal, Allison C. Ostriker, Raja Chakraborty, Chia‐Ling Wu, Zhanxin Yang, Sujatha Muralidharan, Cristina Rius, Jacqueline Vuong, Sophia Jacob, Varsha Muralidhar, Avril A. B. Robertson, Matthew A. Cooper, Vicente Andrés, Karen K. Hirschi, Kathleen A. Martin, Kenneth Walsh Hit paper breakdown →	2017	978
18	Streaming algorithms for identification pathogens and antibiotic resistance potential from real-time MinION™ sequencing GigaScience ·Minh Duc Cao, Devika Ganesamoorthy, Alysha G. Elliott, Huihui Zhang, Matthew A. Cooper, Lachlan Coin	2016	63
19	Novel Compound Cytokine Release Inhibitory Drug 3 (CRID3) Inhibits the NLRP3 Inflammasome in Rheumatoid Arthritis Queensland's institutional digital repository (The University of Queensland) ·Trudy McGarry, Mary Coerver- Connolly, Rebecca C. Coll, Avril A. B. Robertson, Matthew A. Cooper, Luke O'neill, Douglas J. Veale, Ursula Fearon	2014	2
20	Quantification of Small Molecule-Receptor Affinities and Kinetics by Acoustic Profiling Assay and Drug Development Technologies ·Xin Li, Kevin S. J. Thompson, Ben L. J. GODBER, Matthew A. Cooper	2006	10

About Matthew A. Cooper

Matthew A. Cooper is a scholar working on Molecular Medicine, Microbiology, Toxicology, Applied Microbiology and Biotechnology and Molecular Biology, having authored 364 papers that have together received 23.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (41 papers), Inflammasome and immune disorders (36 papers), Antimicrobial Peptides and Activities (35 papers), Advanced biosensing and bioanalysis techniques (20 papers), Acoustic Wave Resonator Technologies (19 papers), Advanced Biosensing Techniques and Applications (17 papers), Crystal Structures and Properties (15 papers) and Antibiotics Pharmacokinetics and Efficacy (15 papers). The work is most often cited by research in Molecular Medicine (1.6k citations), Microbiology (1.5k citations), Molecular Biology (11.9k citations), Biological Psychiatry (422 citations) and Immunology (3.4k citations). Matthew A. Cooper has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Mark S. Butler, Mark A. T. Blaskovich, Avril A. B. Robertson, Philip M. Hansbro, Alysha G. Elliott, Philip Hugenholtz, Dudley H. Williams, David Wood, Mark Morrison and Shaan L. Gellatly. Their work appears in journals such as ACS Infectious Diseases, Journal of Medicinal Chemistry, Australian Journal of Chemistry, Scientific Reports and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact